Dr. McKenna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
909 Fulton St
Minneapolis, MN 55455- Is this information wrong?
Summary
- Dr. David McKenna is a pathologist in Saint Paul, MN. He received his medical degree from Saint Louis University School of Medicine and has been in practice 20 years. He specializes in blood banking & transfusion medicine, transplantation immunology, anatomic pathology, and clinical pathology and is experienced in hematopoietic stem cell transplantation and cellular immunity.
Education & Training
- University of MinnesotaFellowship, Transfusion Medicine, 2001 - 2003
- University of MinnesotaResidency, Pathology-Anatomic and Clinical, 1997 - 2003
- Saint Louis University School of MedicineClass of 1997
Certifications & Licensure
- MN State Medical License 2003 - 2024
- VT State Medical License 1997 - 1998
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
Clinical Trials
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases Start of enrollment: 2007 May 01
- T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer Start of enrollment: 2007 Jul 23
- Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant Start of enrollment: 2008 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Reply to Kaestner et al.: Pioneering quantitative platforms for stored red blood cell assessment open the door for precision transfusion medicine.Ziya Isiksacan, Angelo D'Alessandro, David H McKenna, Shannon N Tessier, Erdem Kucukal, A Aslihan Gokaltun, Nishaka William, Rebecca D Sandlin, John Bischof, Narla Moh...> ;Proceedings of the National Academy of Sciences of the United States of America. 2024 Mar 12
- Safety and virologic impact of haploidentical NK cells plus IL-2 or N-803 in HIV infection.Miller, J., Rhein, J., Davis, Z., Cooley, S., Anderson, J., Escandón, K., Wieking, G., Reichel, J., Thorkelson, A., Jorstad, S., Safrit, J., Schacker, T., McKenna, D.,...> ;The Journal of Infectious Diseases. 2024 Jan 11
- Emerging Biomarkers for Monitoring Chimeric Antigen Receptor T-Cell Therapy.Theodros Mamo, Alexandra Dreyzin, David Stroncek, David H McKenna> ;Clinical Chemistry. 2024 Jan 4
- Join now to see all
Abstracts/Posters
- Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...David H. McKenna, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multip...David H. McKenna, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Groundbreaking U of M Medical School Muscle Regeneration Research Receives Nearly $1 Million GrantSeptember 3rd, 2019
Hospital Affiliations
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: